We're unable to sign you in at this time. Please try again in a few minutes.
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Editorial |

From the Genetic Code to Neuromics

Roger N. Rosenberg, MD
JAMA Neurol. 2013;70(6):684-685. doi:10.1001/jamaneurol.2013.2854.
Text Size: A A A
Published online


In 1968, Marshall Nirenberg won the Nobel Prize in Medicine for deciphering the genetic code. At the time, I was a postdoctoral fellow in his laboratory, the Laboratory of Biochemical Genetics at the National Heart and Lung Institute of the National Institutes of Health. We were working on the molecular differentiation of neuroblastoma cells and neuroblasts from dissociated mouse brain in cell culture. Enzyme activities for neurotransmitter synthesis and degradation were characterized with the degree of morphologic cellular differentiation. These experiments and others of a similar nature represented the beginning of the era of neurobiochemical genetics. Discussions in the laboratory at that time focused on the application of the genetic code and development of methods for deciphering mutations causal of neurological disease. Discussions with Nirenberg included ideas and concepts of potential brain codes for memory and learning. It was a scientifically intense, creative, and productive time for all of us in the laboratory, projecting how the nascent fields of neurogenetics and neurogenomics (neuromics) would unfold and eventually enter the clinic.

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

First Page Preview

View Large
First page PDF preview





Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.


Some tools below are only available to our subscribers or users with an online account.

0 Citations

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

Related Content

Customize your page view by dragging & repositioning the boxes below.

Related Collections
PubMed Articles